This result further demonstrates that loss-of-LC3 expression in both HCC and ANT tissues is associated with a high risk of HCC recurrence, highlighting that LC3 expression significantly predicts HCC recurrence. This evidence concerns the gene MAP1LC3A and hepatocellular carcinoma.